Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trialIan Judson, Winette T.A. van der Graaf, Jeremy Whelan et al.|The Lancet Oncology|2014Cited by 1.2k
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trialSylvie Bonvalot, Rick L. Haas, Alessandro Gronchi et al.|The Lancet Oncology|2020Cited by 482
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramFátima Cardoso, Sharon H. Giordano, John M.S. Bartlett et al.|Annals of Oncology|2017Cited by 396
Preoperative Radiotherapy in Patients With Primary Retroperitoneal SarcomaDario Callegaro, Alessandro Gronchi, Chandrajit P. Raut et al.|Annals of Surgery|2022Cited by 138